Table 3 Results of Cox proportional hazards regression model, with death and recurrence as the response variables
From: p53 mutation, deprivation and poor prognosis in primary breast cancer
Death | Recurrence | |||||
---|---|---|---|---|---|---|
β | P | RR (95% CI) | β | P | RR (95% CI) | |
Deprivation 10 (vs 1–9) | 1.81 | 0.0003 | 6.1 (2.3–16.2) | 1.31 | 0.003 | 3.7 (1.6–8.9) |
Tumour size (large vs small) | 1.22 | 0.003 | 3.4 (1.5–7.5) | 0.83 | 0.012 | 2.3 (1.2–4.4) |
ER (+ vs −) | −2.50 | 0.041 | 0.1 (<0.1–0.9) | −1.28 | 0.056 | 0.3 (0.1–1.0) |
p53 mutation (vs WT) | 0.67 | 0.114 | 1.9 (0.9–4.5) | 0.95 | 0.009 | 2.6 (1.3–5.2) |
Tumour grade (3 vs 1–2) | 0.90 | 0.087 | 2.5 (0.9–6.9) | 0.18 | 0.677 | 1.2 (0.5–2.7) |
Nodal status (+ vs −) | 1.32 | 0.005 | 3.7 (1.5–9.5) | 0.94 | 0.007 | 2.6 (1.3–5.1) |
HER2 status (+ vs −) | −1.96 | 0.121 | 0.1 (<0.1–1.7) | −0.58 | 0.383 | 0.6 (0.2–2.1) |
Triple negative (n vs y) | −1.54 | 0.229 | 0.2 (<0.1–2.6) | −0.74 | 0.325 | 0.5 (0.1–2.1) |
Dep 10 & p53 m (v rest) | 2.52 | <0.0001 | 12.4 (4.8–32.3) | 2.18 | <0.0001 | 8.8 (3.6–21.7) |
Tumour size (large vs small) | 1.26 | 0.002 | 3.5 (1.6–7.7) | 0.90 | 0.005 | 2.5 (1.3–4.7) |
ER (+ vs −) | −2.65 | 0.021 | 0.1 (<0.1–0.7) | −1.47 | 0.023 | 0.2 (0.1–0.8) |
Tumour grade (3 vs 1–2) | 1.07 | 0.033 | 2.9 (1.1–7.8) | 0.35 | 0.369 | 1.4 (0.7–3.0) |
Nodal status (+ vs −) | 1.49 | 0.002 | 4.4 (1.8–11.2) | 1.05 | 0.002 | 2.9 (1.5–5.6) |
HER2 status (+ vs −) | −1.57 | 0.184 | 0.2 (<0.1–2.1) | −0.23 | 0.718 | 0.8 (0.2–2.8) |
Triple negative (n vs y) | −1.55 | 0.199 | 0.2 (<0.1–2.3) | −0.77 | 0.296 | 0.5 (0.1–2.0) |